SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that the newly FDA-approved Wegovy® pill (oral semaglutide) is ...
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced two major initiatives to make FDA-approved GLP-1 medications more ...
End-to-end GLP-1 care done right: only FDA-approved medications and savings that set a new standard for weight management treatment “GoodRx is scaling a consumer-first model for affordable GLP-1 ...
Consumers can soon go to GoodRx (GDRX) for Weight Loss to determine eligibility and obtain a prescription for the first and only oral GLP-1 formulation “We’re excited to help consumers access one of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results